OTC · Drug Manufacturers - Specialty & Generic

Earth Science Tech, Inc. (ETST) Stock

$0.15 +7.14% OTC: ETST Healthcare

Earth Science Tech, Inc. (EST) is a biotechnology firm dedicated to the worldwide development and distribution of nutraceuticals, bioceuticals, and dietary supplements.

Valuation

MetricValue
Price$0.15
Market Cap$43.23M
P/E Ratio12.20
P/B Ratio6.26
P/S Ratio1.21
EPS (TTM)$0.01
52-Week High$0.24
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE66.08%
ROA40.47%
ROCE314.61%
Gross Margin62.85%
Operating Margin62.06%
Net Margin10.17%
Debt/Equity0.01
Current Ratio1.93

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$12.0M$33.0M$36.0M
Operating Profit$0$0$1.0M$3.0M$4.0M
Net Profit$3.0M$0$1.0M$3.0M$4.0M
EPS$0.06$0.00$0.00$0.01$0.01
Op Margin-1552.1%-823.5%11.0%10.4%12.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$3.0M$4.0M$7.0M$9.0M
Total Liabilities$2.0M$2.0M$2.0M$3.0M$2.0M
Cash$0$0$1.0M$1.0M$1.0M
Borrowings$1.0M$1.0M$0$0$0

Latest News

Earth Science Tech, Inc. Reports Fiscal Year-End Financial Results for March 31, 2026 GlobeNewswire · Jun 18, 2026 ETST Increasing Revenue and Improving Margins Zacks Small Cap Research · Jun 18, 2026 Earth Science Tech, Inc. (ETST) Annual Shareholder Letter for FY Ended March 31, 2026 GlobeNewswire · Jun 10, 2026 Earth Science Tech, Inc. (ETST) to Present at the Planet MicroCap Las Vegas 2026 Investor Conference Powered by MicroCapClub GlobeNewswire · Jun 3, 2026 ETST Transition Worth Paying Attention To Zacks Small Cap Research · May 12, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$-1.0M$1.0M$4.0M$2.0M
Investing Cash Flow$0$0$0$-3.0M$-3.0M
Financing Cash Flow$0$0$0$-1.0M$0
Net Cash Flow$0$0$1.0M$1.0M$-1.0M
Free Cash Flow$0$-1.0M$1.0M$4.0M$1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.88
EV / EBITDA12.54
FCF Yield2.74%
Quick Ratio1.58
Interest Coverage93.86
Return 1Y-25.00%
Return 3Y105.48%
Return 5Y787.57%

Ownership

Insiders Held66.70%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
DBCCFDecibel Cannabis Company Inc. $0.08 -0.08% -20.00 $44.71M 0.00%
DXBRFBellRock Brands Inc. $0.00 0.00 $53153 0.00%
FLOOFFlower One Holdings Inc. $0.00 -0.03 $4731 0.00%
INISRadnostix, Inc. $0.06 -8.17% 0.00 $30.42M 0.00%
MILFF1CM Inc. $0.10 +0.00% 3.27 $12.06M 0.00%

About Earth Science Tech, Inc.

Earth Science Tech, Inc. (EST) is a biotechnology firm dedicated to the worldwide development and distribution of nutraceuticals, bioceuticals, and dietary supplements. These offerings aim to support general health, overall well-being, nutrition, and address specific needs within the cosmetic and alternative medicine sectors. The company's nutritional and dietary supplements are specifically formulated to help manage a wide range of conditions, including chronic and joint discomfort, inflammation, seizures, hypertension, cognitive decline, mood imbalances, weight management, nausea, and the physiological effects of aging, while also promoting overall vitality. EST's diverse product portfolio features items such as various hemp oils, essential vitamins and minerals, a broad selection of herbal and botanical extracts, personal care solutions, homeopathic remedies, and functional food products. These are offered in numerous forms, including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herb preparations. Distribution channels include the company's own retail store, medical clinics, pharmacies, and online platforms. In addition to its wellness products, Earth Science Tech also provides medical equipment and devices. Founded in 2010, the company initially operated under the name Ultimate Novelty Sports, Inc. before officially rebranding to Earth Science Tech, Inc. in March 2014. Its corporate headquarters are located in Doral, Florida.

Earth Science Tech, Inc. is headquartered in US.

Earth Science Tech, Inc. (ETST) stock trades at $0.15 with a market capitalization of $43.23M. The stock is valued at a price-to-earnings (P/E) ratio of 12.20, price-to-book of 6.26, price-to-sales of 1.21. Over the past 52 weeks the stock has ranged between $0.00 and $0.24, and currently trades 37.5% below its 52-week high.

On profitability, Earth Science Tech, Inc. generates a return on equity (ROE) of 66.08% — well above the market average, a sign of a high-quality business, return on capital employed of 314.61%, an operating margin of 62.06%, a net profit margin of 10.17%.

Official website: www.earthsciencetech.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides